William Blair Initiates Coverage On Zura Bio with Outperform Rating

Benzinga Newsdesk www.benzinga.com Positive 68.8%

Neg 0% Neu 0% Pos 68.8%

William Blair analyst Matt Phipps initiates coverage on Zura Bio (NASDAQ:ZURA) with a Outperform rating.

Comments

No comments yet. Be the first!